Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Avirmax Biopharma Inc

Clinical trials sponsored by Avirmax Biopharma Inc, explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

One-Shot gene therapy could replace monthly eye injections for wet AMD Results expected Jan 2027 (estimated)

Browse trials soon ready across all sponsors →

Not yet finished but already full! 1

One-Shot gene therapy could replace monthly eye injections for wet AMD

Disease control Ongoing

This early-stage trial tests a single injection of ABI-110 gene therapy into the eye for people with wet age-related macular degeneration (AMD), a leading cause of vision loss. The goal is to see if it is safe and can reduce the need for frequent anti-VEGF injections by helping t…

Phase 1/2 • Sponsor: Avirmax Biopharma Inc • Aim: Disease control

Last updated Jun 27, 2026 09:04 UTC